Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

An urgent call to CERN, IEEE, and the scientific community to engage with verifiable evidence, fulfill scientific duty, and resolve contradictions based on the laws of nature, not institutional ...

Regal Rexnord Corporation (NYSE: RRX) ...